Documents | Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion | Guidance | NICE

Documents

A list of downloadable documents created during development.

Background information

Macular oedema (retinal vein occlusion) - dexamethasone: review decision - January 2015 information
Macular oedema (retinal vein occlusion) - dexamethasone: appendix A ^{PDF 76.62 KB} 26 January 2015
Macular oedema (retinal vein occlusion) - dexamethasone: review proposal November 2014 information
Macular oedema (retinal vein occlusion) - dexamethasone: Appendix B - proposal paper presented to the Institutes Guidance Executive ^{PDF 295.09 KB} 17 November 2014
Macular oedema (retinal vein occlusion) - dexamethasone: Appendix A - provisional matrix of stakeholders ^{PDF 36.3 KB} 17 November 2014

Macular oedema (retinal vein occlusion) - dexamethasone: equality impact assessment

Macular oedema (retinal vein occlusion) - dexamethasone: equality impact assessment ^{PDF 68.56 KB} 27 July 2011

Macular oedema (retinal vein occlusion) - dexamethasone: final appraisal determination

Macular oedema (retinal vein occlusion) - dexamethasone: final appraisal determination information
Macular oedema (retinal vein occlusion) - dexamethasone: final appraisal determination document ^{PDF 247.63 KB} 06 June 2011
Response to consultee, commentator and public comments on the Appraisal Consultation Document (ACD) ^{PDF 178.82 KB} 06 June 2011
Consultee and commentator comments on the ACD
Allergan cover letter ^{PDF 192.77 KB} 06 June 2011
Allergen response to ACD ^{PDF 460.43 KB} 06 June 2011
Allergan additional analysis ^{PDF 855.46 KB} 06 June 2011
Appendices to the additional analysis ^{PDF 735.75 KB} 06 June 2011
RNIB ACD comments ^{PDF 57.33 KB} 06 June 2011
RCO ACD comments ^{PDF 102.96 KB} 06 June 2011
RCN ACD comments ^{PDF 50.89 KB} 06 June 2011
NHS Waltham Forest ACD comments ^{PDF 287.92 KB} 06 June 2011
Comments on the ACD received from the public through the NICE website
NHS Wirrall ^{PDF 28.68 KB} 06 June 2011
NHS Bradford and Airedale ^{PDF 46.43 KB} 06 June 2011
Additional ERG critique post ACD by Aberdeen HTA Group ^{PDF 1.04 MB} 10 June 2011

Macular oedema (retinal vein occlusion) - dexamethasone: appraisal consultation

Macular oedema (retinal vein occlusion) - dexamethasone: appraisal consultation
Macular oedema (retinal vein occlusion) - dexamethasone: appraisal consultation document information
Macular oedema (retinal vein occlusion) - dexamethasone: evaluation report
Macular oedema (retinal vein occlusion) - dexamethasone: pre-meeting briefing ^{PDF 290.48 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: final scope ^{PDF 60.75 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: final matrix ^{PDF 48.96 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: manufacturer submissions
Macular oedema (retinal vein occlusion) - dexamethasone: submission from Allergan Pharmaceuticals ^{PDF 7.87 MB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: submission from Allergan Pharmaceuticals - additional analyses ^{PDF 2.67 MB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: clarification letters
Macular oedema (retinal vein occlusion) - dexamethasone: NICE request to the manufacturer for clarification on their submission ^{PDF 135.45 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: Manufacturer's response to NICE's request for clarification ^{PDF 870.54 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: non-manufacturer submissions
Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) ^{PDF 60.22 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study A ^{PDF 8.62 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study B ^{PDF 36.34 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study C ^{PDF 8.69 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: submission from Macular Disease Society and Royal National Institute of Blind People (RNIB) (joint submission) - case study D ^{PDF 10.79 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: submission from Royal College of Nursing ^{PDF 60.73 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: submission from Royal College of Ophthalmologists ^{PDF 118.88 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: submission from Royal College of Ophthalmologists - Interim Guidelines for Management of Retinal Vein Occlusion ^{PDF 286.67 KB} 08 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statements
Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - McLaughlan ^{PDF 17.15 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - Pearce ^{PDF 18.33 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - Read ^{PDF 19.96 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: expert personal statement - Taylor ^{PDF 11.37 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: evidence review group report
Macular oedema (retinal vein occlusion) - dexamethasone: Evidence Review Group report ^{PDF 1.47 MB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: Evidence Review Group report - additional analyses ^{PDF 157.77 KB} 07 February 2011
Macular oedema (retinal vein occlusion) - dexamethasone: Evidence Review Group report - factual accuracy check ^{PDF 65.22 KB} 07 February 2011

Macular oedema (retinal vein occlusion) - dexamethasone: final scope

Macular oedema (retinal vein occlusion) - dexamethasone: final scope ^{PDF 60.75 KB} 05 August 2010

Macular oedema (retinal vein occlusion) - dexamethasone: final matrix

Macular oedema (retinal vein occlusion) - dexamethasone: final matrix ^{PDF 47.58 KB} 05 August 2010

Macular oedema (retinal vein occlusion) - dexamethasone: Institute's response to consultee and commentator comments on the draft scope

Macular oedema (retinal vein occlusion) - dexamethasone: Institute's response to consultee and commentator comments on the draft scope ^{PDF 185.66 KB} 05 August 2010

Macular oedema (retinal vein occlusion) - dexamethasone: Institute's response to consultee and commentator comments on the draft scope

Macular oedema (retinal vein occlusion) - dexamethasone: Institute's response to consultee and commentator comments on the draft scope ^{PDF 42.58 KB} 05 August 2010

Appendix B: draft scope for consultation (pre-referral)

Appendix B: draft scope for consultation (pre-referral) ^{PDF 34.16 KB} 12 July 2010

Appendix C: provisional matrix (pre-referral)

Appendix C: provisional matrix (pre-referral) ^{PDF 30.35 KB} 12 July 2010